Informed-money record

PCSA · Processa Pharmaceuticals, Inc.

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

Bearish filings

Named actors

Disclosed $ (bull / bear)

$166K / $0

Recent disclosures

25 of 34 in the window · linked to source

Date	Who	What	Disclosed $	Receipt
2026-08-18	5%+ holder (13G) Soleus Capital Master Fund, L.P.	disclosed a passive stake (13G)	—	SEC ↗
2026-07-01	Chief Executive Officer Ng George K	bought	$6K	SEC ↗
2026-06-30	Pres. Research & Development Young David	bought	$5K	SEC ↗
2026-06-30	Chief Financial Officer SKIBSTED RUSSELL	bought	$6K	SEC ↗
2026-06-30	Chief Business - Strategy Off Lin Patrick	bought	$4K	SEC ↗

9 more disclosures in the window — the full record, scoring, and validation are for members.

Want the read, not just the record?

Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.

Create a free account →

Dispute or correct this record

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals